E-LIB Suche - Ergebnisse für: Katoh, Miki

1

Changes in uridine 5′‐diphospho‐glucuronosyltransferase 1A6..:

Sakakibara, Yukiko ; Kojima, Ayaka ; Asai, Yuki..
Biopharmaceutics & Drug Disposition. 43 (2022) 5 - p. 175-182 , 2022

Link: https://doi.org/10.1002/..

2

The Effect of Single-Walled Carbon Nanotubes on UDP-Glucuro..:

Asai, Yuki ; Nadai, Masayuki ; Katoh, Miki
Biological and Pharmaceutical Bulletin. 45 (2022) 4 - p. 446-451 , 2022

Link: https://doi.org/10.1248/..

3

P45 - Determination and comparison of skin and plasma conce..:

Kojima, Ayaka ; Katoh, Miki ; Asai, Yuki.
Drug Metabolism and Pharmacokinetics. 35 (2020) 1 - p. S34-S35 , 2020

Link: https://doi.org/10.1016/..

4

P9 - Effects of histone deacetylase inhibitor on UGT1A1 and..:

Katoh, Miki ; Asai, Yuki ; Goto, Shoko.
Drug Metabolism and Pharmacokinetics. 35 (2020) 1 - p. S25 , 2020

Link: https://doi.org/10.1016/..

5

Effects of Thylakoid-Rich Spinach Extract on the Pharmacoki..:

Saito, Yuji ; Usami, Tomoaki ; Katoh, Miki.
Biological and Pharmaceutical Bulletin. 42 (2019) 1 - p. 103-109 , 2019

Link: https://doi.org/10.1248/..

6

Status Epilepticus Decreases Brain Cytochrome P450 2D4 Expr..:

Asai, Yuki ; Tanaka, Hatsuna ; Nadai, Masayuki.
Journal of Pharmaceutical Sciences. 107 (2018) 4 - p. 975-978 , 2018

Link: https://doi.org/10.1016/..

7

Effect of single‐walled carbon nanotubes on cytochrome P450..:

Asai, Yuki ; Sakakibara, Yukiko ; Inoue, Rina...
Biopharmaceutics & Drug Disposition. 39 (2018) 5 - p. 275-279 , 2018

Link: https://doi.org/10.1002/..

8

Effect of status epilepticus on expression of brain UDP-glu..:

Asai, Yuki ; Tanaka, Hatsuna ; Nadai, Masayuki.
Biopharmaceutics & Drug Disposition. 39 (2017) 2 - p. 75-82 , 2017

Link: https://doi.org/10.1002/..

9

Characterization of β-Estradiol 3-Glucuronidation in Rat Br..:

Asai, Yuki ; Sakakibara, Yukiko ; Onouchi, Haruka..
Biological & Pharmaceutical Bulletin; Biological and Pharmaceutical Bulletin. 40 (2017) 9 - p. 1556-1560 , 2017

Link: https://doi.org/10.1248/..

10

Species and Tissue Differences in β-Estradiol 17-Glucuronid..:

Asai, Yuki ; Sakakibara, Yukiko ; Kondo, Miyabi..
Biological & Pharmaceutical Bulletin; Biological and Pharmaceutical Bulletin. 40 (2017) 10 - p. 1754-1758 , 2017

Link: https://doi.org/10.1248/..

11

Effect of single-walled carbon nanotubes on expression of p..:

Katoh, Miki ; Kuwabara, Yukinori ; Sakakibara, Yukiko..
Drug Metabolism and Pharmacokinetics. 32 (2017) 1 - p. S35 , 2017

Link: https://doi.org/10.1016/..

12

Investigation of characteristics of estradiol 3-glucuronida..:

Asai, Yuki ; Katoh, Miki ; Sakakibara, Yukiko..
Drug Metabolism and Pharmacokinetics. 32 (2017) 1 - p. S36 , 2017

Link: https://doi.org/10.1016/..

13

Effect of carbamazepine on expression of UDP-glucuronosyltr..:

Asai, Yuki ; Sakakibara, Yukiko ; Nadai, Masayuki.
Drug Metabolism and Pharmacokinetics. 32 (2017) 6 - p. 286-292 , 2017

Link: https://doi.org/10.1016/..

14

Effects of β-Naphthoflavone on Ugt1a6 and Ugt1a7 Expression..:

Sakakibara, Yukiko ; Katoh, Miki ; Kondo, Yuya.
Biological & Pharmaceutical Bulletin; Biological and Pharmaceutical Bulletin. 39 (2016) 1 - p. 78-83 , 2016

Link: https://doi.org/10.1248/..

15

Expression of UGT1A subfamily in rat brain:

Sakakibara, Yukiko ; Katoh, Miki ; Imai, Kuniyuki...
Biopharmaceutics & Drug Disposition. 37 (2016) 5 - p. 314-319 , 2016

Link: https://doi.org/10.1002/..